Annals of Surgical Oncology

, Volume 16, Issue 7, pp 1727–1733

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

  • Mark P. Callery
  • Kenneth J. Chang
  • Elliot K. Fishman
  • Mark S. Talamonti
  • L. William Traverso
  • David C. Linehan
ORIGINAL ARTICLE – CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER

DOI: 10.1245/s10434-009-0408-6

Cite this article as:
Callery, M.P., Chang, K.J., Fishman, E.K. et al. Ann Surg Oncol (2009) 16: 1727. doi:10.1245/s10434-009-0408-6

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  • Mark P. Callery
    • 1
  • Kenneth J. Chang
    • 2
  • Elliot K. Fishman
    • 3
  • Mark S. Talamonti
    • 4
  • L. William Traverso
    • 5
  • David C. Linehan
    • 6
  1. 1.Department of SurgeryBeth Israel Deaconess Medical CenterBostonUSA
  2. 2.Gastrointestinal Oncology Program, Irvine Medical CenterUniversity of CaliforniaOrangeUSA
  3. 3.Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins University School of MedicineBaltimoreUSA
  4. 4.Department of SurgeryJohns Hopkins University School of MedicineBaltimore USA
  5. 5.Department of General, Vascular and Thoracic SurgeryVirginia Mason ClinicSeattleUSA
  6. 6.Department of SurgeryWashington University School of MedicineSt. LouisUSA